Immunolocalization of androgen receptor in canine prostatic hyperplasia effect of antiandrogen

Tokai Journal of Experimental and Clinical Medicine

Volumn 23, Issue 5, 1998, Pages 209-212

  Murakoshi, Masanori ^a   Ikeda, Rie ^b   Tagawa, Masashi ^b   Nakayama, Takaharu ^b   Honma, Seijiroh ^b   Mieda, Mamoru ^b  

^a Grelan Pharmaceutical Co Ltd   (Japan)

^b NONE

Author keywords

Androgen receptor (AR); Benign prostatic hyperplasia (BPH); Chlormadinone acetate (CMA); Fibro muscular stroma; Glandular hyperplasia of prostate

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; CHLORMADINONE ACETATE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY COMBINING SITE; ARTICLE; CONTROLLED STUDY; DOG; DRUG BINDING SITE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; RECEPTOR DENSITY;

ANDROGEN ANTAGONISTS; ANIMALS; CHLORMADINONE ACETATE; DOGS; MALE; ORGAN SIZE; PROSTATE; PROSTATIC HYPERPLASIA; RECEPTORS, ANDROGEN;

EID: 0032419477     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. DeKlerk D.P., Coffey D.S., Ewing L.L., Mcdermott I.R., Reiner WG, Robinson C.H., Talalay J.D., Walsh P.C.: Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest 64: 842-849, 1979.
2. Forti G., Salerno R., Moneti G., Zoppi S., Fiorelli G., Martini T., Natali A., Castantini A., Serio M., Martini L., Motta M.: Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostate hyperplasia. J Clin Endocrinol Metab 68: 461-468, 1989.
3. Geller J., Fishman J., Cantor T.L.: Effect of cyproterone acetate on clinical endocrine and pathological features of benign prostatic hypertrophy. J Steroid Biochem 6: 837-843, 1975.
4. Graham R.C. Karnovsky M.J.: The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney. J Histochem Cytochem 14: 291-302, 1966.
5. Huang J.K., Bartsch W., Voit K.D.: Interaction of an antiandrogen (Cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate. Acta Endocrinol 109: 569-576, 1985.
6. Ito Y., Kurosawa I, Yamanaka H., Koya A., Imai K., Kasaku N., Shida K.: The mechanism of antiandrogenic action of chlormadinone acetate. Hinyokika Kiyo 68: 537-552, 1977.
7. Mizokami A., Masai M., Shimazaki J., Sugita A: Production of polyclonal antibody against human androgen receptor and immunohistochemical study of human androgen receptor in prostatic tissues. Jpn J Urol 83: 1801-1807, 1992.
8. Murakoshi M., Inada R., Tagawa M., Suzuki M., Mizokami A., Watanabe K.: Histopathological and immunohistochemical studies in the rat ventral prostate. J Toxicol Pathol. 6: 55-64, 1993.
9. Murakoshi M., Inada R., Tagawa M., Suzuki M., Mizokami A., Watanabe K.: Histopathological and immunohistochemical studies in the rat dorsolateral prostate. J Toxicol Pathol 7: 387-395, 1994.
10. Murakoshi M., Inada R., Tagawa M., Mizokami A., Suzuki M.: Immunohistochemical study of androgen receptor in rat prostatic hyperplasia. Acta Histochem Cytochem 27: 75-80, 1994.
11. Sar M., Lubahn D.B., French F.S., Wilson E.M.: Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 127: 3180-3186, 1990.
12. Walsh P.C., Wilson J.D.: The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 57: 1093-1097, 1976.
13. Zamboni L., DcMartino C: Buffered picrinic acid formaldehyde. A new rapid fixation for electron microscopy. J Cell Biol 35: 148A, 1967.